Supply Chain in the Pharmaceutical Industry

Strategic Influences and Supply Chain Responses

Business & Finance, Management & Leadership, Management
Cover of the book Supply Chain in the Pharmaceutical Industry by Rob Whewell, Taylor and Francis
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Rob Whewell ISBN: 9781317048336
Publisher: Taylor and Francis Publication: April 1, 2016
Imprint: Routledge Language: English
Author: Rob Whewell
ISBN: 9781317048336
Publisher: Taylor and Francis
Publication: April 1, 2016
Imprint: Routledge
Language: English

The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.

More books from Taylor and Francis

Cover of the book Economic Integration in the Americas by Rob Whewell
Cover of the book Reflections of a Neuropsychologist by Rob Whewell
Cover of the book Darwinian Misadventures in the Humanities by Rob Whewell
Cover of the book The Routledge Handbook of Language Learning and Technology by Rob Whewell
Cover of the book Getting There by Design by Rob Whewell
Cover of the book Governing Natural Resources for Africa’s Development by Rob Whewell
Cover of the book Kosovo, Intervention and Statebuilding by Rob Whewell
Cover of the book Jap Foreign Pol 1869-1942 V11 by Rob Whewell
Cover of the book Contestatory Cosmopolitanism by Rob Whewell
Cover of the book Authority, Innovation and Early Modern Epistemology by Rob Whewell
Cover of the book Peacemaking in a Divided Society by Rob Whewell
Cover of the book Human Rights, Islam and the Failure of Cosmopolitanism by Rob Whewell
Cover of the book The Break-up of Yugoslavia and International Law by Rob Whewell
Cover of the book Popular Contention in Great Britain, 1758-1834 by Rob Whewell
Cover of the book IT in Business: A Business Manager's Casebook by Rob Whewell
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy